All Stories

  1. Urinary beta-2 microglobulin increases whereas TIMP-2 and IGFBP7 decline after unilateral nephrectomy in healthy kidney donors
  2. Hypertension and diabetes, but not leptin and adiponectin, mediate the relationship between body fat and chronic kidney disease
  3. Effect of lipid-lowering therapies on C-reactive protein levels: a comprehensive meta-analysis of randomized controlled trials
  4. Differences in mental health status during the COVID-19 pandemic between patients undergoing in-center hemodialysis and peritoneal dialysis
  5. Health-related quality of life and symptom burden in patients on haemodialysis
  6. Urinary Kidney Injury Biomarkers Are Associated with Ischemia-Reperfusion Injury Severity in Kidney Allograft Recipients
  7. Clinical and patient-reported trajectories at end-of-life in older patients with advanced CKD
  8. Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-up
  9. The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease
  10. Association of omega 3 polyunsaturated fatty acids with incident chronic kidney disease: pooled analysis of 19 cohorts
  11. Effect of residual kidney function and dialysis adequacy on chronic pruritus in dialysis patients
  12. The association between TMAO, CMPF, and clinical outcomes in advanced chronic kidney disease: results from the European QUALity (EQUAL) Study
  13. Symptom Burden before and after Dialysis Initiation in Older Patients
  14. Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients
  15. Reference intervals of urinary kidney injury biomarkers for middle-aged men and women determined by quantitative protein mass spectrometry
  16. The Epidemiology of Diabetic Kidney Disease
  17. Environmental factors and mobility predict COVID-19 seasonality in the Netherlands
  18. Quality of Life before and after the Start of Dialysis in Older Patients
  19. Depression, anxiety and quality of life of hemodialysis patients before and during the COVID-19 pandemic
  20. Internet-based treatment for depressive symptoms in hemodialysis patients: A cluster randomized controlled trial
  21. Itching in dialysis patients: impact on health-related quality of life and interactions with sleep problems and psychological symptoms—results from the RENINE/PROMs registry
  22. Health-Related Quality-of-Life Trajectories over Time in Older Men and Women with Advanced Chronic Kidney Disease
  23. Association Between Lipophilic Beta-Blockers and Depression in Diabetic Patients on Chronic Dialysis
  24. Serum Potassium and Mortality Risk in Hemodialysis Patients: A Cohort Study
  25. Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study
  26. The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease
  27. Comparable seasonal pattern for COVID-19 and flu-like illnesses
  28. Variation in glucocorticoid sensitivity and the relation with obesity
  29. Environmental factors and mobility predict COVID-19 seasonality
  30. Plasma fatty acids and kidney function decline in post-myocardial infarction patients of the Alpha Omega Cohort
  31. Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD
  32. Can pollen explain the seasonality of flu-like illnesses in the Netherlands?
  33. DIALysis or not: Outcomes in older kidney patients with GerIatriC Assessment (DIALOGICA): rationale and design
  34. The predictive value of TIMP-2 and IGFBP7 for kidney failure and 30-day mortality after elective cardiac surgery
  35. Lower gastrointestinal bleeding in a patient receiving sevelamer: Case report
  36. A Randomized Trial of Liposomal Prednisolone (LIPMAT) to Enhance Radiocephalic Fistula Maturation: A Pilot Study
  37. Superior Long-Term Survival for Simultaneous Pancreas–Kidney Transplantation as Renal Replacement Therapy: 30-Year Follow-up of a Nationwide Cohort
  38. Effect of different types of statins on kidney function decline and proteinuria: a network meta-analysis
  39. Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients
  40. Dutch nOcturnal and hoME dialysis Study To Improve Clinical Outcomes (DOMESTICO): rationale and design
  41. Low Birth Weight and Kidney Function in Middle-Aged Men and Women: The Netherlands Epidemiology of Obesity Study
  42. Association of Initiation of Maintenance Dialysis with Functional Status and Caregiver Burden
  43. Dietary protein intake and kidney function decline after myocardial infarction: the Alpha Omega Cohort
  44. Geriatric Assessment and the Relation with Mortality and Hospitalizations in Older Patients Starting Dialysis
  45. Publisher Correction: Lower body mass index and mortality in older adults starting dialysis
  46. Lower body mass index and mortality in older adults starting dialysis
  47. Thoracic and abdominal pain in a 28-year-old woman with a failing kidney transplant
  48. Cardiovascular Risk Factors Accelerate Kidney Function Decline in Post−Myocardial Infarction Patients: The Alpha Omega Cohort Study
  49. Dyslipidemia and risk of renal replacement therapy or death in incident pre-dialysis patients
  50. Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial
  51. Body-fat indicators and kidney function decline in older post-myocardial infarction patients: The Alpha Omega Cohort Study
  52. Obesity and risk of death or dialysis in younger and older patients on specialized pre-dialysis care
  53. Effect of dual compared to no or single renin-angiotensin system blockade on risk of renal replacement therapy or death in predialysis patients: PREPARE-2 study
  54. MP375DYSLIPIDEMIA AND RISK OF RENAL REPLACEMENT THERAPY OR DEATH IN PRE-DIALYSIS PATIENTS: PREPARE-2 STUDY
  55. SP055CARDIOVASCULAR RISK FACTORS, LIFESTYLE AND KIDNEY FUNCTION DECLINE IN STABLE OLDER POST-MYOCARDIAL INFARCTION PATIENTS RECEIVING OPTIMAL DRUG THERAPY: A PROSPECTIVE COHORT STUDY
  56. Listeria Endocarditis: A Diagnostic Challenge
  57. Kidney function and specific mortality in 60-80 years old post-myocardial infarction patients: A 10-year follow-up study
  58. Kidney dysfunction, systemic inflammation and mental well-being in elderly post-myocardial infarction patients
  59. Mortality reduction by post-dilution online-haemodiafiltration: a cause-specific analysis
  60. MP316BODY MASS INDEX AND KIDNEY FUNCTION DECLINE IN 60-80 YEARS OLD STATE-OF-THE-ART DRUG-TREATED POST-MYOCARDIAL INFARCTION PATIENTS
  61. SP293DUAL COMPARED TO SINGLE RENIN-ANGIOTENSIN SYSTEM INHIBITION AND RISK OF RENAL REPLACEMENT THERAPY OR DEATH IN PREDIALYSIS PATIENTS: PREPARE-2 STUDY
  62. The Effect of Online Hemodiafiltration on Infections: Results from the CONvective TRAnsport STudy
  63. Recipient obesity and outcomes after kidney transplantation: a systematic review and meta-analysis
  64. Effect of Omega-3 Fatty Acids on Kidney Function after Myocardial Infarction: The Alpha Omega Trial
  65. Online hemodiafiltration reduces systemic inflammation compared to low-flux hemodialysis
  66. Uric acid: association with rate of renal function decline and time until start of dialysis in incident pre-dialysis patients
  67. No effect of n-3 fatty acids supplementation on NT-proBNP after myocardial infarction: The Alpha Omega Trial
  68. Resistance to Erythropoiesis Stimulating Agents in Patients Treated with Online Hemodiafiltration and Ultrapure Low-Flux Hemodialysis: Results from a Randomized Controlled Trial (CONTRAST)
  69. Clinical Predictors of Decline in Nutritional Parameters over Time in ESRD
  70. No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial
  71. The cost–utility of haemodiafiltration versus haemodialysis in the Convective Transport Study
  72. An uncommon cause of Staphylococcus aureus sepsis
  73. Should We Still Focus That Much on Cardiovascular Mortality in End Stage Renal Disease Patients? The CONvective TRAnsport STudy
  74. Hepcidin-25 is related to cardiovascular events in chronic haemodialysis patients
  75. Association of Blood Pressure with the Start of Renal Replacement Therapy in Elderly Compared with Young Patients Receiving Predialysis Care
  76. Hepcidin-25 in Chronic Hemodialysis Patients Is Related to Residual Kidney Function and Not to Treatment with Erythropoiesis Stimulating Agents
  77. Membranous nephropathy with predominance of C1q: another variant of C1q nephropathy?
  78. Obesity and Mortality Risk among Younger Dialysis Patients
  79. Differences in quality of life of hemodialysis patients between dialysis centers
  80. Effect of Obesity on the Outcome of Kidney Transplantation: A 20-Year Follow-Up
  81. Role of Residual Renal Function in Phosphate Control and Anemia Management in Chronic Hemodialysis Patients
  82. Haemodialysis catheters increase mortality as compared to arteriovenous accesses especially in elderly patients
  83. Pre-dialysis patients' perceived autonomy, self-esteem and labor participation: associations with illness perceptions and treatment perceptions. A cross-sectional study
  84. Changes in quality of life over time--Dutch haemodialysis patients and general population compared
  85. A composite score of protein-energy nutritional status predicts mortality in haemodialysis patients no better than its individual components
  86. A haemodialysis patient with back pain: brown tumour as a cause of spinal cord compression under cinacalcet therapy
  87. Reversible Rapidly Progressive Dementia with Parkinsonism Induced by Valproate in a Patient with Systemic Lupus Erythematosus
  88. Short-term Effects of Online Hemodiafiltration on Phosphate Control: A Result From the Randomized Controlled Convective Transport Study (CONTRAST)
  89. Exclusion of a Case-Control Study From Meta-analysis
  90. Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
  91. Associations between pre-kidney-transplant risk factors and post-transplant cardiovascular events and death
  92. Evaluation of the one-minute exercise test to detect peripheral arterial disease
  93. Unusual presentation of tumoral calcinosis in chronic renal failure: a case report
  94. Homocysteine and Risk of Ischemic Heart Disease and Stroke
  95. Hyperhomocysteinemia, Diabetes, and Cardiovascular Disease
  96. Hyperhomocysteinemia Is Associated With the Presence of Retinopathy in Type 2 Diabetes Mellitus
  97. Hyperhomocysteinemia Increases Risk of Death, Especially in Type 2 Diabetes
  98. Hyperhomocysteinaemia is not associated with isolated crural arterial occlusive disease: The Hoorn Study
  99. Classification of Congenital Anomalies of the Upper Limb
  100. Hyperhomocysteinaemia is not related to risk of distal somatic polyneuropathy: The Hoorn Study
  101. Reply from the authors
  102. The association of dietary fibres with glucose tolerance is partly explained by concomitant intake of thiamine: The Hoorn Study
  103. Serum homocysteine level and protein intake are related to risk of microalbuminuria: The Hoorn Study11See Editorial by Robinson and Dennis, p 281
  104. Correspondence
  105. Effects of Sex Steroids on Plasma Total Homocysteine Levels: A Study in Transsexual Males and Females
  106. Effects of Sex Steroids on Plasma Total Homocysteine Levels: A Study in Transsexual Males and Females
  107. Hyperhomocysteinemia Is Associated With an Increased Risk of Cardiovascular Disease, Especially in Non–Insulin-Dependent Diabetes Mellitus
  108. Does metformin increase the serum total homocysteine level in non-insulin-dependent diabetes mellitus?